| Antibodies |
|
| CD71 M-A712 BV421 |
BD Biosciences |
Cat#562995; RRID: AB_2737939
|
| CD4 SK3 BV650 |
BD Biosciences |
Cat#563875; RRID: AB_2744425
|
| CD27 L128 BV711 |
BD Biosciences |
Cat#563167; RRID: AB_2738042
|
| CD38 HIT2 BV786 |
BD Biosciences |
Cat#563964; RRID: AB_2738515
|
| CCR7 150503 AF700 |
BD Biosciences |
Cat#561143; RRID: AB_10562031
|
| CD14 MΦP9 APC-H7 |
BD Biosciences |
Cat#560180; RRID: AB_1645464
|
| CD19 SJ25C1 APC-H7 |
BD Biosciences |
Cat#560177; RRID: AB_1645470
|
| CD45RA HI100 FITC |
BD Biosciences |
Cat#555488; RRID: AB_395879
|
| CD8a SK1 PerCP-Cy5.5 |
BD Pharmingen |
Cat#565310; RRID: AB_2687497
|
| CD95 DX2 PE-CF594 |
BD Biosciences |
Cat#562395; RRID: AB_11153666
|
| PD-1 EH12.1 PE-Cy7 |
BD Biosciences |
Cat#561272; RRID: AB_10611585
|
| CD3 OKT3 BV510 |
BioLegend |
Cat#317332; RRID: AB_2561943
|
| HLA-DR L243 BV605 |
BioLegend |
Cat#307640; RRID: AB_2561913
|
| CXCR5 RF8B2 BV421 |
BD Biosciences |
Cat#562747; RRID: AB_2737766
|
| CD19 SJ25C1 BV510 |
BD BioSciences |
Cat#562947; RRID: AB_2737912
|
| CCR6 11A9 BV650 |
BD Biosciences |
Cat#563922; RRID: AB_2738488
|
| CD20 2H7 BV711 |
BD Biosciences |
Cat#563126; RRID: AB_2313579
|
| CD27 M-T271 AF700 |
BD Biosciences |
Cat#560611; RRID: AB_1727454
|
| CD4 RPA-T4 APC-H7 |
BD Biosciences |
Cat#560158; RRID: AB_1645478
|
| CD3 UCHT1 PE-CF594 |
BD Biosciences |
Cat#562280; RRID: AB_11153674
|
| CXCR3 (CD183) 1C6 APC |
BD Biosciences |
Cat#550967; RRID: AB_398481
|
| CD8 SK1 FITC |
BD Biosciences |
Cat#555634; RRID: AB_395996
|
| CD45 HI30 PerCPCy5.5 |
BD Biosciences |
Cat#340953; RRID: AB_400194
|
| ICOS (CD278) DX29 PE |
BD Biosciences |
Cat#557802; RRID: AB_396878
|
| CD8a SK1 BV605 |
BD Biosciences |
Cat#564116; RRID: AB_2869551
|
| CD25 2A3 BV711 |
BD Biosciences |
Cat#563159; RRID: AB_2738037
|
| CXCR3 G025H7 BV785 |
BioLegend |
Cat#353738; RRID: AB_2565924
|
| APC (4-1BB) 4B4-1 CD137 |
BioLegend |
Cat#309810; RRID: AB_830672
|
| CD69 FN50 PerCPCy5.5 |
BioLegend |
Cat#310926; RRID: AB_2074956
|
| CD134 L106 PE |
BD Biosciences |
Cat#340420; RRID: AB_400027
|
| CD45RA L48 PECy7 |
BD Biosciences |
Cat#337167; RRID: AB_647424
|
| CD19 J4.119 ECD |
Beckman Coulter |
Cat#IM2708U; RRID:AB_130854
|
| IgM G20-127 BUV395 |
BD Biosciences |
Cat#563903; RRID:AB_2721269
|
| CD21 B-ly4 BUV737 |
BD Biosciences |
Cat#564437; RRID:AB_2738807
|
| IgD IA6-2 PE-Cy7 |
BD Biosciences |
Cat#561314; RRID:AB_10642457
|
| IgG G18-145 BV786 |
BD Biosciences |
Cat#564230; RRID:AB_2738684
|
| CD27 O323 BV605 |
BioLegend |
Cat#302829; RRID:AB_11204431
|
| Streptavidin PE |
BD Biosciences |
Cat#554061, RRID:AB_10053328
|
| Streptavidin APC |
BD Biosciences |
Cat#554067, RRID:AB_10050396
|
| Peroxidase AffiniPure goat anti-human IgG, Fcγ fragment specific |
Jackson ImmunoResearch |
Cat#109-035-098; RRID: AB_2337586
|
|
| Biological samples |
|
| Blood samples (peripheral blood mononuclear cells (PBMCs) and plasma samples) from COVID-19-vaccinated adult haematological malignancy patients and healthy control individuals |
The Royal Melbourne Hospital, The Austin Hospital, St Vincent’s Hospital, and The Peter McCallum Cancer Center |
N/A |
|
| Chemicals, peptides, and recombinant proteins |
|
| 3,3′,5,5′-Tetramethylbenzidine (TMB) Liquid Substrate System for ELISA, peroxidase substrate |
Sigma |
Cat#T0440-1L |
| Alkaline phosphatase yellow (pNPP) liquid substrate for ELISA |
Sigma |
Cat#P7998-100ML |
| Pierce High Sensitivity Streptavidin-HRP |
Thermo Fisher Scientific |
Cat#21130 |
| SARS-CoV-2 RBD protein |
Amanat et al.,40
|
N/A |
| SARS-CoV-2 Spike protein |
Juno et al.,37
|
N/A |
| SARS-CoV-2 peptides – A1/ORF1a1637 TTDPSFLGRY; A1/S865-873 LTDEMIAQY; A2/S269 YLQPRTFLL; A3/N361 KTFPPTEPK; A3/S378 KTFPPTEPK; A24/S1208 QYIKWPWYI; B7/N105-113 SPRWYFYYL; B15/S919-927 NQKLIANQF; B35/S321-329 QPTESIVRF; and DPB4/S167 TFEYVSQPFLMDLE |
GenScript |
N/A |
| HLA-A∗01:01/S865 monomer (SARS-CoV-2, S865, LTDEMIAQY) |
Peptide sequence30, monomer [Rossjohn Laboratory] |
N/A |
| HLA-A∗01:01/ORF1a1637 monomer (SARS-CoV-2, ORF1a1637, TTDPSFLGRY) |
Peptide sequence41, monomer21
|
N/A |
| HLA-A∗03:01/S378 monomer (SARS-CoV-2, S378, KCYGVSPTK) |
Peptide sequence41, monomer [Rossjohn Laboratory] |
N/A |
| HLA-A∗03:01/N361 monomer (SARS-CoV-2, N361, KTFPPTEPK) |
Peptide sequence42, monomer21
|
N/A |
| HLA-B∗07:02/N105 monomer (SARS-CoV-2, N105, SPRWYFYYL) |
Peptide sequence42, monomer18
|
N/A |
| HLA-B∗15:01/S919 monomer (SARS-CoV-2, S919, NQKLIANQF) |
Peptide sequence23, monomer [Rossjohn Laboratory] |
N/A |
| HLA-A∗02:01/S269 monomer (SARS-CoV-2, S269, YLQPRTFLL) |
Peptide sequence/monomer19
|
N/A |
| HLA-B∗35:01/S321 monomer (SARS-CoV-2, S321, QPTESIVRF) |
Peptide sequence33, monomer [Rossjohn Laboratory] |
N/A |
| HLA-A∗24:02/S1208 monomer (SARS-CoV-2, S1208, QYIKWPWYI) |
Peptide sequence31, monomer20
|
N/A |
| HLA-DPA1∗01:03/DPB1∗04:01/S167 monomer (SARS-CoV-2, S167, TFEYVSQPFLMDLE) |
Peptide sequence/monomer22
|
N/A |
|
| Software and algorithms |
|
| R v4.2.1 |
R Core Team,43
|
https://cran.r-project.org |
|
conga package |
Schattgen et al.44
|
https://github.com/phbradley/conga |
| igraph R package v1.3.2 |
Csárdi and Nepusz45
|
https://igraph.org/r/ |
| TCRdist pipeline |
Dash et al.46
|
https://github.com/phbradley/tcr-dist |
| Gephi v0.9.7 |
Jacomy et al.47
|
https://gephi.org/ |
| Corrplot v0.92 |
Wei and Simko48
|
https://github.com/taiyun/corrplot |
| rstatix pacakage v0.7.0 |
Kassambara49
|
https://CRAN.R-project.org/package=rstatix |
| EnhancedVolcano v1.14.0 |
Blighe et al.50
|
https://github.com/kevinblighe/EnhancedVolcano |
| FlowJo v10.5.3 |
FlowJo |
https://www.flowjo.com |
| Prism v8.3.1 or v9.1.0 |
GraphPad |
https://www.graphpad.com |
| BD FACS Diva v8.0.1 |
BD Biosciences |
https://www.bdbiosciences.com/en-us/instruments/research-instruments/research-software/flow-cytometry-acquisition/facsdiva-software |
|
| Other |
|
| Anti-PE Micro-Beads |
Miltenyi Biotec |
Cat# 130-048-801, RRID:AB_244373
|
| Anti-APC Micro-Beads |
Miltenyi Biotec |
Cat# 130-090-855, RRID:AB_244367
|